surmount 4 tirzepatide Continued Treatment With for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial Tirzepatide once weekly for the

This broader approach allows patients to manage multiple health concerns through a single telehealth platform while maintaining privacy, convenience, and ongoing medical support

This option may be especially helpful for adults who are: Living with insulin resistance, prediabetes, or type 2 diabetes Carrying excess weight that increases blood sugar or cardiovascular risk Interested in weight loss plus heart protection The medication is also approved to reduce major cardiovascular events in people with established heart disease and obesity

Iacobellis et al., 2017

save intense cold for off-days to avoid blunting adaptation